Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 230039생성일: 2026년 10월 24일
N-Ethylpiperidine → (3s,4r)-3-[(1r)-1-(Tert-butyldimethylsilyloxy)ethyl]-4-[(1r)-1-methyl-2-[7-dimethoxymethyl(pyridin-3-yl)imidazo[5,1-b]thiazol-2-yl]-2-oxoethyl]azetidin-2-one
https://huagongshe.com/ko/reaction/230039
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | N-Ethylpiperidine | HCID 13007 | — |
| 반응물 | Sodium Bicarbonate | HCID 516892 | — |
| 반응물 | Tin(II) trifluoromethanesulfonate | HCID 2776843 | — |
| 반응물 | (3R,4R)-4-Acetoxy-3-((R)-(tert-butyldimethylsilyloxy)ethyl)-2-azetidinone | HCID 13073890 | — |
| 반응물 | 2-Propionyl-7-(pyridin-3-yl)dimethoxymethylimidazo[5,1-b]thiazole | HCID 68821100 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | (3s,4r)-3-[(1r)-1-(Tert-butyldimethylsilyloxy)ethyl]-4-[(1r)-1-methyl-2-[7-dimethoxymethyl(pyridin-3-yl)imidazo[5,1-b]thiazol-2-yl]-2-oxoethyl]azetidin-2-one | HCID 68821587 | — |
반응 단계
Methylene chloride (2 ml) was added to 0.69 g of tin(II) trifluoromethanesulfonate under an argon atmosphere, and the mixture was cooled to −20° C. A solution of 0.25 g of 2-propionyl-7-(pyridin-3-yl)dimethoxymethylimidazo[5,1-b]thiazole in 1.5 ml of methylene chloride and 0.12 ml of N-ethylpiperidine were added thereto, and the mixture was stirred for 2 hr. A solution of 0.14 g of (3S,4R)-4-acetoxy-3-[(1R)-1-tert-butyldimethylsilyloxyethyl]azetidin-2-one in 1 ml of methylene chloride was added at 0° C., and the mixture was stirred at room temperature for one hr. A saturated aqueous sodium bicarbonate solution was added to the reaction mixture to stop the reaction, and the reaction mixture was extracted with ethyl acetate. The organic layer was washed with a 5% aqueous sodium bicarbonate solution and a 20% aqueous sodium chloride solution in that order and was dried over anhydrous magnesium sulfate. The solvent was removed by evaporation, and the residue was analyzed by HPLC (Cosmosil 5C18-MS, 4.6×150 mm, a 70% aqueous acetonitrile solution). As a result, it was found that the yield of (3S,4R)-3-[(1R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(1R)-1-methyl-2-[7-dimethoxy(pyridin-3-yl)methylimidazo[5,1-b]thiazol-2-yl]-2-oxoethyl]azetidin-2-one was 45 mg. The results of analysis by NMR were in agreement with the results of analysis in Example 18.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07563901B2 |
|---|
| 출처 데이터셋 | uspto-grants-2009_07 |
|---|
| ORD ID | ord-c0f6e14cadd44475a35018cc9c527f1a |
|---|
| 출처 메모 | uspto-grants-2009_07 |
|---|